We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Industry Puzzles Over FDA’s Updated Guidance on Clinical Decision Support Software
Industry Puzzles Over FDA’s Updated Guidance on Clinical Decision Support Software
The FDA’s attempt to clarify its draft guidance on clinical decision support (CDS) software raised new questions, devicemakers said in written comments to the agency.
To View This Article:
Login
Subscribe To International Devices & Diagnostics Monitor